drugset / Trial / NCT01231334

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

NCT01231334

Phase 4 Completed 286 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

Timeline

Start
2010-08
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzoyl Peroxide Other / unclassified Topical
Comparator Clindamycin Unknown Topical
Comparator Dapsone Small molecule 5 % Topical
Comparator Adapalene Other / unclassified 0.3 % Topical

Indications